TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
OGN

Organon & Co

Healthcare · Drug Manufacturers - General

13.70$ -0.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement OGN
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
-6.9% -20.5% -16.0% -3.5% -2.1% +1.4% +2.2% -2.9%
+2.3% -51.5% -6.8% +12.4% -3.7% +9.6% +6.9% +6.2%
-14.0% +8.2% -19.8% -11.1% -1.1% -3.4% -0.9% -9.5%
+2.8% -39.7% -4.5% +111.0% +6.3% +12.1% -11.2% -22.0%
-12.3% -30.2% -1.9% +23.7% +1.2% +16.2% -7.7% +10.7%
-9.9% -30.1% -5.8% +28.2% +8.4% +11.3% -7.9% -6.4%
-17.3% +42.2% -26.0% -32.7% -11.0% -22.2% +12.0% -13.5%
+114.3% -86.7% +0.0% +4,200.0% +63.6% +24.9% -1.3% -3.1%
-11.9% +35.4% -25.5% -44.4% -26.6% -40.0% +19.9% -47.3%
-55.6% -32.3% +27.2% -64.1% +15.2% -270.7%
+19.5% +49.5% -32.9% -37.5% -32.1% +11.6% -15.5% -78.4%
-13.8% -10.6% -23.7% -33.7% -11.4% -18.2% +11.7% -20.1%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?